483 related articles for article (PubMed ID: 25277682)
1. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
Wang P; Xie K; Wang C; Bi J
Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
[TBL] [Abstract][Full Text] [Related]
2. Peroxidation of lipoproteins in multiple sclerosis.
Ferretti G; Bacchetti T
J Neurol Sci; 2011 Dec; 311(1-2):92-7. PubMed ID: 21967834
[TBL] [Abstract][Full Text] [Related]
3. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
[TBL] [Abstract][Full Text] [Related]
4. Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients.
Vijayaraghavan R; Suribabu CS; Sekar B; Oommen PK; Kavithalakshmi SN; Madhusudhanan N; Panneerselvam C
Eur J Clin Nutr; 2005 Oct; 59(10):1121-8. PubMed ID: 16015260
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis.
Sanoobar M; Eghtesadi S; Azimi A; Khalili M; Jazayeri S; Reza Gohari M
Int J Neurosci; 2013 Nov; 123(11):776-82. PubMed ID: 23659338
[TBL] [Abstract][Full Text] [Related]
6. Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial.
Khalili M; Eghtesadi S; Mirshafiey A; Eskandari G; Sanoobar M; Sahraian MA; Motevalian A; Norouzi A; Moftakhar S; Azimi A
Nutr Neurosci; 2014 Jan; 17(1):16-20. PubMed ID: 23485514
[TBL] [Abstract][Full Text] [Related]
7. Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.
Ghabaee M; Jabedari B; Al-E-Eshagh N; Ghaffarpour M; Asadi F
Int J Neurosci; 2010 Apr; 120(4):301-4. PubMed ID: 20374079
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.
Koch M; Ramsaransing GS; Arutjunyan AV; Stepanov M; Teelken A; Heersema DJ; De Keyser J
J Neurol; 2006 Apr; 253(4):483-7. PubMed ID: 16283096
[TBL] [Abstract][Full Text] [Related]
9. Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.
Ortiz GG; Pacheco-Moisés FP; Bitzer-Quintero OK; Ramírez-Anguiano AC; Flores-Alvarado LJ; Ramírez-Ramírez V; Macias-Islas MA; Torres-Sánchez ED
Clin Dev Immunol; 2013; 2013():708659. PubMed ID: 24174971
[TBL] [Abstract][Full Text] [Related]
10. Glutathione in multiple sclerosis: more than just an antioxidant?
Carvalho AN; Lim JL; Nijland PG; Witte ME; Van Horssen J
Mult Scler; 2014 Oct; 20(11):1425-31. PubMed ID: 24842957
[TBL] [Abstract][Full Text] [Related]
11. Lipid peroxidation and total antioxidant status in patients with breast cancer.
Sener DE; Gönenç A; Akinci M; Torun M
Cell Biochem Funct; 2007; 25(4):377-82. PubMed ID: 16447143
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
13. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
14. Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients.
Bartova R; Petrlenicova D; Oresanska K; Prochazkova L; Liska B; Turecky L; Durfinova M
Neuro Endocrinol Lett; 2016; 37(2):102-6. PubMed ID: 27179571
[TBL] [Abstract][Full Text] [Related]
15. Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients.
Naseri A; Forghani N; Sadigh-Eteghad S; Shanehbandi D; Asadi M; Nasiri E; Talebi M
Mult Scler Relat Disord; 2022 Jan; 57():103432. PubMed ID: 34922253
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis.
Sánchez-López AL; Ortiz GG; Pacheco-Moises FP; Mireles-Ramírez MA; Bitzer-Quintero OK; Delgado-Lara DLC; Ramírez-Jirano LJ; Velázquez-Brizuela IE
Arch Med Res; 2018 Aug; 49(6):391-398. PubMed ID: 30595364
[TBL] [Abstract][Full Text] [Related]
17. A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.
Miller ED; Dziedzic A; Saluk-Bijak J; Bijak M
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284389
[TBL] [Abstract][Full Text] [Related]
18. Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Adamczyk-Sowa M; Sowa P; Pierzchala K; Polaniak R; Labuz-Roszak B
J Physiol Pharmacol; 2012 Dec; 63(6):683-90. PubMed ID: 23388485
[TBL] [Abstract][Full Text] [Related]
19. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
